A Study to Evaluate the Efficacy and Safety of HAT01H in Atopic Dermatitis

NCT03089229 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
30
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Haus Bioceuticals